MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-AP-10-0013339
Assurgen Pharma Private Limited - pharma in Visakhapatnam, Andhra Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹41.36 Cr
▼ 3% YoY
Net loss · FY 2025
₹2.07 Cr
Net margin -5%
EBITDA · FY 2025
₹5.09 Cr
EBITDA margin 12.3%
Authorised capital
₹80 Cr
Registered with MCA
Paid-up capital
₹75.46 Cr
Issued & subscribed
Open charges
₹23.5 Cr
Satisfied ₹23.29 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
135
Provident fund records
About Assurgen Pharma Private Limited
Data last updated:
Assurgen Pharma Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 10 October 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24232AP2013PTC090442. Its GSTIN is 37AAMCA3380Q1ZZ (Andhra Pradesh).
The company has an authorised share capital of ₹80 Cr and a paid-up capital of ₹75.46 Cr. It is led by directors including Nagendra Rao Kukalakunta (Managing Director) and Naveen Parupalli.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Visakhapatnam, Andhra Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹41.36 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹2.07 Cr (net margin -5%) and EBITDA of ₹5.09 Cr (EBITDA margin 12.3%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 3% over five years.
The company has about 135 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Treatment Possible and Assurgen Pharma. As per MCA filings, the company has open charges of ₹23.5 Cr and satisfied charges of ₹23.29 Cr on record. Court records list 19 cases involving the company, including 10 filed by the company and 9 filed against it; 5 cases are pending. The company has 12 deals on record (6 secondary share transfers, 5 rights issues, 1 funding round), with disclosed funding of ₹4.28 Cr; the latest was in March 2022. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Jai Lara Drugs Private Limited with revenue of ₹41.75 Cr.
Assurgen Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0013339). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website assurgenpharma.com.
Company Details of Assurgen Pharma Private Limited
CIN U24232AP2013PTC090442
Registration Number 090442
Incorporation Date 10 October 2013
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-AP-10-0013339
Key People
Nagendra Rao Kukalakunta Managing Director Naveen Parupalli Director Paidi Lakshman Rao Director Recognitions & Rankings of Assurgen Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.23E Lalamkoduru Village Rambilli Mandal Apsez Denotified Area At, Chutapuram, Visakhapatnam, Andhra Pradesh, India – 531011
- IndustryPharma, API Manufacturers
Comprehensive company report
Assurgen Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Assurgen Pharma Private Limited
Assurgen Pharma operates two associated brands: Treatment Possible and Assurgen Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Standalone multi speciality clinic | treatmentpossible.com | |
| Produces high-quality active pharmaceutical ingredients (APIs). | assurgenpharma.com |
Business Activity of Assurgen Pharma Private Limited
The main business activity of Assurgen Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Assurgen Pharma Private Limited FY 2024 filings available
Assurgen Pharma Private Limited reported revenue of ₹41.36 Cr (down 3% YoY) for FY 2025.
Revenue · FY 2025
₹41.36 Cr ▼ 3%
Net loss · FY 2025
₹2.07 Cr margin -5%
EBITDA · FY 2025
₹5.09 Cr margin 12.3%
Compounded Annual Growth Rate (CAGR) of Assurgen Pharma Private Limited
Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▼ 5%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 192%
3 years · compounded
▲ 45%
5 years · compounded
▲ 30%
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA rose 192% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Assurgen Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.09 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.07 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Assurgen Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Assurgen Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Assurgen Pharma Private Limited
Assurgen Pharma has 7 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naveen Parupalli | Director | 10 Oct 2013 | 13 Years 0 Months | Current |
| Paidi Lakshman Rao | Director | 15 Nov 2014 | 11 Years 11 Months | Current |
| Srinivasa Rao Vayetla | Director | 30 Nov 2017 | 8 Years 10 Months | Current |
| Johann Danklmaier | Director | 02 Jul 2024 | 2 Years 3 Months | Current |
| Ravi Kumar Potluri | Director | 20 Dec 2016 | 9 Years 10 Months | Current |
| Nagendra Rao Kukalakunta | Managing Director | 10 Oct 2013 | 13 Years 0 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer Comparison of Assurgen Pharma Private Limited
Assurgen Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jai Lara Drugs Private Limited | ₹41.75 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Hyderabad, Telangana, India |
| Polydrug Laboratories Private Limited | ₹41.72 Cr (FY 2024) | •••• | •••• | 238.0% | •••• | Mumbai, Maharashtra, India |
| Phanicare Pharmaceuticals Private Limited | ₹41.7 Cr (FY 2024) | •••• | •••• | -18.0% | •••• | Hyderabad, Telangana, India |
| Qualikems Lifesciences Private Limited | ₹41.7 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Vadodara, Gujarat, India |
| Accrete Pharmaceuticals Private Limited | ₹41.49 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Hyderabad, Telangana, India |
| Assurgen Pharma Private Limited this company | ₹41.36 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
| Elixir Pharma Chem Private Limited | ₹41.04 Cr (FY 2025) | •••• | •••• | 86.0% | •••• | Ahmedabad, Gujarat, India |
| Stermone Chemicals Private Limited | ₹40.62 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Khambhat, Gujarat, India |
| Erythro Pharma Private Limited | ₹40.06 Cr (FY 2025) | •••• | •••• | 48.0% | •••• | Hyderabad, Telangana, India |
| Cureworth Drugs & Intermediates Private Limited | ₹40.05 Cr (FY 2025) | •••• | •••• | 79.0% | •••• | Panvel, Maharashtra, India |
| Viswa Laboratories Private Limited | ₹39.96 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Assurgen Pharma by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Assurgen Pharma Private Limited
Assurgen Pharma Private Limited is audited by K Ramalinga Swamy & Co for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K Ramalinga Swamy & Co | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Assurgen Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Assurgen Pharma Private Limited
Open charges
₹23.5 Cr
Satisfied charges
₹23.29 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2021 | Hdfc Bank Limited | ₹23.5 Cr | Open |
| 28 Jan 2019 | Others | ₹80 Lakh | Satisfied |
| 05 Aug 2017 | Others | ₹4 Cr | Satisfied |
| 27 Mar 2017 | Others | ₹2.49 Cr | Satisfied |
| 24 Nov 2015 | Andhra Pradesh State Financial Corporation. | ₹16 Cr | Satisfied |
Total charge records: 5 View all charges
Deals & Funding of Assurgen Pharma Private Limited
Assurgen Pharma Private Limited has 12 deals on record (6 secondary share transfers, 5 rights issues, 1 funding round), with disclosed funding of ₹4.28 Cr; the latest was in March 2022.
Total deals
12
Secondary share transfers
6
Rights issues
5
Funding round
1
Disclosed funding
₹4.28 Cr
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: G.L. Pharma GmbH Seller: 2 individuals |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Srimannaryana Traders LLP , an individual |
| May 2018 | Rights issue | ₹2.35 Cr | Investors: Srimannaryana Traders LLP , 2 individuals |
| Dec 2017 | Funding round | ₹4.28 Cr | Investors: Srimannaryana Traders LLP |
Premium access
Full deal history
All 12 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Assurgen Pharma Private Limited
Assurgen Pharma Private Limited has 19 court cases on record: 10 filed by Assurgen Pharma, 9 filed against it. 5 cases are pending and 14 are disposed.
Total cases
19
Filed by the company
10
Filed against the company
9
Pending
5
Disposed
14
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 16 | 8 | 4 |
| High courts | 3 | 1 | 1 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Visakapatnam, Andhra Pradesh | Civil suit | Filed by the company against Qualitek Pharma Pvt.Ltd | Pending |
| High Court of Andhra Pradesh | Appeal | Filed by the company against Union of India | Pending |
| District court, Visakapatnam, Andhra Pradesh | Criminal case | Filed by the company against R.T.Pharma | Pending |
| District court, Visakapatnam, Andhra Pradesh | Criminal case | Filed by the company against M/S.P.T.Pharma | Pending |
| District court, Visakapatnam, Andhra Pradesh | Criminal case | Filed by the company against M/S. P.T.Pharma | Pending |
Premium access
Full case history
All 19 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Assurgen Pharma Private Limited
Assurgen Pharma Private Limited has a workforce of 135 employees as of Mar 28, 2024.
Employee count
135
Active EPFO establishments
2
Employee growth
7.14%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Assurgen Pharma Private Limited
Assurgen Pharma Private Limited has 14 board changes on record since 2013: 7 appointments and 7 cessations. The latest: Johann Danklmaier ceased to be Additional Director on 29 Sep 2024.
AGM
Assurgen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Johann Danklmaier ceased to be Additional Director.
Appointed
Johann Danklmaier was appointed as Director.
Filing
Assurgen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
Ceased
Paidi Lakshman Rao ceased to be Director.
Charges
A charge with Hdfc Bank Limited of Rs. 23.50 Cr registered on 30 Oct 2021 with Charge ID 100514026 was modified on 26 Oct 2022.
Charges
A charge registered on 27 Mar 2017 via Charge ID 100088373 with Others was fully satisfied on 04 Jan 2022.
Charges
A charge registered on 24 Nov 2015 via Charge ID 10604135 with Andhra Pradesh State Financial Corporation. was fully satisfied on 04 Jan 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 23.50 Cr with Charge ID 100514026 was registered on 30 Oct 2021.
Charges
A charge registered on 05 Aug 2017 via Charge ID 100179549 with Others was fully satisfied on 01 Dec 2020.
Charges
A charge registered on 28 Jan 2019 via Charge ID 100241732 with Others was fully satisfied on 21 Aug 2019.
Appointed
Dr Georg Stark was appointed as Director.
16 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Assurgen Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Assurgen Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Assurgen Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Assurgen Pharma Private Limited
Assurgen Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAMCA3380Q1ZZ | Andhra Pradesh | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Assurgen Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Assurgen Pharma Private Limited
Assurgen Pharma is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 10 October 2013 (13+ years old) and is registered under CIN U24232AP2013PTC090442.
Assurgen Pharma reported revenue of ₹41.36 Cr for FY 2025 (down 3% YoY).
Assurgen Pharma has 7 current directors:
- Nagendra Rao Kukalakunta - Managing Director
- Naveen Parupalli - Director
- Paidi Lakshman Rao - Director
- Srinivasa Rao Vayetla - Director
- Johann Danklmaier - Director
- Ravi Kumar Potluri - Director
- Dr Georg Stark - Director
Assurgen Pharma reported a net loss of ₹2.07 Cr (net margin -5%) and EBITDA of ₹5.09 Cr (EBITDA margin 12.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Assurgen Pharma is -5% over three years and 3% over five years. In the latest year (FY 2025) revenue fell 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Assurgen Pharma is 37AAMCA3380Q1ZZ, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Assurgen Pharma is U24232AP2013PTC090442. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Assurgen Pharma has 19 court cases on record: 10 filed by the company and 9 filed against it. 5 are pending. Most are in the district courts.
Assurgen Pharma was incorporated on 10 October 2013, making it 13+ years old. It is registered with the Registrar of Companies, Vijayawada.
Assurgen Pharma has 12 deals on record (6 secondary share transfers, 5 rights issues, 1 funding round), with disclosed funding of ₹4.28 Cr; the latest was in March 2022.
The peers of Assurgen Pharma by revenue are Jai Lara Drugs Private Limited, Polydrug Laboratories Private Limited, Phanicare Pharmaceuticals Private Limited, Qualikems Lifesciences Private Limited, Accrete Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (API Manufacturers).